Fennec Pharmaceuticals Inc. (FENC) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Fennec Pharmaceuticals Inc. (FENC) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

FENC Income Statement

Fennec Pharmaceuticals Inc. (FENC) annual income statement — 26-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	17.87M	15.11M	13.78M	12.46M	9.65M	8.75M	7.92M	6.97M	7.26M	25.38M	9.73M	6.51M	3.33M	1.68M	1.53M	0	0	0	0	0
Revenue Growth %	85.18%	72.64%	73.84%	78.69%	32.91%	-65.52%	-18.59%	7.05%	118.41%	1413.24%	534.2%	-	-	-	-	-	-	-	-100%	-
Cost of Goods Sold	721K	570K	1.76M	660K	967K	373K	669K	1.36M	608K	550K	685K	331K	148K	95K	86K	0	0	0	0	0
COGS % of Revenue	4.03%	3.77%	12.8%	5.3%	10.02%	4.26%	8.44%	19.46%	8.37%	2.17%	7.04%	5.08%	4.45%	5.66%	5.6%	-	-	-	-	-
Gross Profit	17.15M	14.54M	12.01M	11.8M	8.69M	8.38M	7.26M	5.62M	6.65M	24.83M	9.05M	6.18M	3.18M	1.58M	1.45M	0	0	0	0	0
Gross Margin %	95.97%	96.23%	87.2%	94.7%	89.98%	95.74%	91.56%	80.54%	91.63%	97.83%	92.96%	94.92%	95.55%	94.34%	94.4%	-	-	-	-	-
Gross Profit Growth %	97.5%	73.53%	65.56%	110.11%	30.52%	-66.25%	-19.82%	-9.17%	109.44%	1469.34%	524.57%	-	-	-	-	-	-	-	-100%	-
Operating Expenses	15.42M	14.66M	14.59M	12M	11.42M	9.2M	8.21M	10.84M	11.69M	11.08M	10.87M	7.2M	7.84M	6.85M	7.67M	7.9M	5.01M	3.55M	4.21M	4.17M
OpEx % of Revenue	86.25%	97.01%	105.92%	96.32%	118.29%	105.12%	103.66%	155.43%	161.02%	43.68%	111.64%	110.53%	235.88%	408.59%	499.67%	-	-	-	-	-
Selling, General & Admin	15.3M	14.61M	14.55M	11.96M	11.31M	9.09M	8.14M	10.72M	11.54M	11.08M	10.84M	7.19M	7.83M	6.85M	7.47M	7.05M	3.88M	2.11M	3.68M	2.93M
SG&A % of Revenue	85.59%	96.69%	105.59%	95.99%	117.18%	103.9%	102.71%	153.74%	158.85%	43.67%	111.31%	110.35%	235.64%	408.35%	486.45%	-	-	-	-	-
Research & Development	118K	49K	20K	29K	107K	94K	50K	97K	157K	3K	32K	12K	8K	4K	117K	846K	1.13M	1.44M	523K	1.24M
R&D % of Revenue	0.66%	0.32%	0.15%	0.23%	1.11%	1.07%	0.63%	1.39%	2.16%	0.01%	0.33%	0.18%	0.24%	0.24%	7.62%	-	-	-	-	-
Other Operating Expenses	0	0	26K	12K	0	13K	25K	21K	0	0	0	0	0	0	86K	0	0	0	0	0
Operating Income	1.74M	-119K	-2.58M	-201K	-2.73M	-821K	-959K	-5.22M	-5.04M	13.74M	-1.82M	-1.02M	-4.67M	-5.27M	-6.13M	-7.9M	-5.01M	-3.55M	-4.21M	-4.17M
Operating Margin %	9.72%	-0.79%	-18.73%	-1.61%	-28.31%	-9.38%	-12.1%	-74.89%	-69.39%	54.16%	-18.67%	-15.61%	-140.33%	-314.25%	-399.67%	-	-	-	-	-
Operating Income Growth %	163.58%	85.51%	-169.03%	96.15%	45.78%	-105.97%	47.25%	-413.57%	-7.99%	360.78%	70.37%	87.13%	6.85%	-48.62%	-45.83%	-89.29%	-27.78%	27.97%	-25.73%	28.78%
EBITDA	1.76M	-93K	-2.55M	-175K	-2.71M	-795K	-933K	-5.2M	-5.01M	14.47M	-1.75M	-939K	-4.72M	-5.22M	-6.11M	-7.83M	-5.01M	-3.54M	-4.2M	-4.17M
EBITDA Margin %	9.86%	-0.62%	-18.54%	-1.4%	-28.05%	-9.08%	-11.77%	-74.53%	-69.03%	57%	-17.96%	-14.41%	-141.89%	-311.15%	-398.24%	-	-	-	-	-
EBITDA Growth %	165.13%	88.3%	-173.74%	96.63%	46%	-105.5%	46.62%	-453.57%	-6.25%	377.23%	71.41%	88.02%	5.92%	-47.44%	-45.58%	-88.12%	-25.63%	25.16%	-25.49%	24.33%
D&A (Non-Cash Add-back)	26K	26K	26K	26K	25K	26K	26K	25K	26K	723K	70K	0	-52K	52K	0	64K	0	7K	8K	8K
EBIT	1.74M	208K	-4.37M	-52K	-2.56M	-573K	-654K	-4.71M	-4.51M	13.87M	-1.77M	-1.01M	-4.62M	-5.25M	-6.11M	-7.97M	-5.01M	-3.64M	-4.37M	-4.13M
Net Interest Income	284K	332K	-80K	-434K	-443.18K	-367.88K	-592K	-509K	-497K	-837K	-800K	-754K	-793.34K	-689K	-661K	-95K	-47.59K	-49K	12.96K	-41.71K
Interest Income	287K	339K	228K	152K	173.82K	235.29K	374K	516K	570K	197K	115K	102K	116.52K	109K	153K	24K	8.92K	9K	12.96K	12.91K
Interest Expense	3K	7K	308K	586K	617K	603.17K	966K	1.02M	1.07M	1.03M	915K	856K	909.86K	798K	815.23K	119K	56.51K	58K	-	54.63K
Other Income/Expense	278K	320K	-2.1M	-437K	-420K	-344K	-661K	-512K	-514K	-906K	-864K	-850K	-778K	-782K	-722K	-190K	-63K	-150K	-220K	-12K
Pretax Income	2.02M	201K	-4.68M	-638K	-3.15M	-1.17M	-1.62M	-5.74M	-5.55M	12.84M	-2.68M	-1.87M	-5.44M	-6.05M	-6.86M	-8.09M	-5.07M	-3.7M	-4.43M	-4.18M
Pretax Margin %	11.27%	1.33%	-33.98%	-5.12%	-32.66%	-13.31%	-20.44%	-82.23%	-76.47%	50.59%	-27.55%	-28.66%	-163.73%	-360.88%	-446.71%	-	-	-	-	-
Income Tax	42K	0	106K	0	0	0	365K	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	2.08%	0%	-2.26%	0%	0%	0%	-22.53%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	1.97M	201K	-4.79M	-638K	-3.15M	-1.17M	-1.99M	-5.74M	-5.55M	12.84M	-2.68M	-1.87M	-5.44M	-6.05M	-6.86M	-8.09M	-5.07M	-3.7M	-4.43M	-4.18M
Net Margin %	11.04%	1.33%	-34.75%	-5.12%	-32.66%	-13.31%	-25.05%	-82.23%	-76.47%	50.59%	-27.55%	-28.66%	-163.73%	-360.88%	-446.71%	-	-	-	-	-
Net Income Growth %	162.6%	117.25%	-141.16%	88.88%	43.24%	-109.08%	25.99%	-207.18%	-2%	312.11%	60.89%	76.92%	-7.33%	-63.74%	-54.89%	-93.29%	-26.77%	21.91%	-36.72%	32.5%
Net Income (Continuing)	1.97M	201K	-4.79M	-638K	-3.15M	-1.17M	-1.99M	-5.74M	-5.55M	12.84M	-2.68M	-1.87M	-5.44M	-6.05M	-6.86M	-8.09M	-5.07M	-3.7M	-4.43M	-4.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.05	0.01	-0.17	-0.02	-0.12	-0.04	-0.06	-0.21	-0.20	0.41	-0.10	-0.07	-0.21	-0.29	-0.30	-0.31	-0.19	-0.15	-0.17	-0.16
EPS Growth %	141.67%	113.27%	-196.68%	89.1%	40%	-110.29%	42.7%	-200%	4.76%	241.38%	66.67%	77.42%	-10.53%	-93.33%	-76.47%	-93.75%	-26.67%	16.67%	-21.43%	33.33%
EPS (Basic)	0.06	0.01	-0.17	-0.02	-0.12	-0.04	-0.07	-0.21	-0.20	0.47	-0.10	-0.07	-0.21	-0.29	-0.30	-0.31	-0.19	-0.15	-0.17	-0.16
Diluted Shares Outstanding	36.43M	35.55M	31.18M	27.89M	27.66M	27.58M	27.46M	27.37M	27.3M	31.09M	26.83M	26.46M	26.46M	26.56M	26.36M	26.11M	26.05M	26.02M	26.01M	26.01M
Basic Shares Outstanding	34.55M	34.34M	31.18M	27.89M	27.66M	27.58M	27.46M	27.37M	27.3M	27.05M	26.83M	26.46M	26.46M	26.56M	26.36M	26.09M	26.05M	26.02M	26.01M	26.01M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-